Vaccination Utilizing the FimCH Complex As a Strategy to PreventEscherichia coliUrinary Tract Infections
Open Access
- 1 March 2001
- journal article
- review article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 183 (s1) , S84-S86
- https://doi.org/10.1086/318857
Abstract
The significant medical and economic burden caused by uncomplicated UTIs in otherwise healthy women makes this population an important target for vaccination. IKeywords
This publication has 15 references indexed in Scilit:
- Type 1 pilus-mediated bacterial invasion of bladder epithelial cellsThe EMBO Journal, 2000
- Vaccination with FimH Adhesin Protects Cynomolgus Monkeys from Colonization and Infection by UropathogenicEscherichia coliThe Journal of Infectious Diseases, 2000
- Induction and Evasion of Host Defenses by Type 1-Piliated Uropathogenic Escherichia coliScience, 1998
- Urinary Tract Infection: An OverviewThe Lancet Healthy Longevity, 1997
- Prevention of Mucosal Escherichia coli Infection by FimH-Adhesin-Based Systemic VaccinationScience, 1997
- Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract.Proceedings of the National Academy of Sciences, 1996
- In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections.Proceedings of the National Academy of Sciences, 1996
- An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli.Proceedings of the National Academy of Sciences, 1985
- Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolateInfection and Immunity, 1981
- The Role of Vaginal Colonization with Enterobacteriaceae in Recurrent Urinary InfectionsJournal of Urology, 1975